NYSE: IGC - IGC Pharma, Inc.

六个月盈利: -31.13%
股息率: 0.00%
部门: Healthcare

促销时间表 IGC Pharma, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 IGC Pharma, Inc.

IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development.

更多详情
It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2006-04-13
ISIN US45408X3089
Industry Trading Companies & Distributors
Sector Industrials
Валюта usd
Валюта отчета usd
Сайт https://igcpharma.com
Цена ао 0.31
每日价格变化: -2% (0.3)
每周价格变化: -8.13% (0.32)
每月价格变化: +5% (0.28)
3个月内价格变化: -20.54% (0.37)
六个月内的价格变化: -31.13% (0.4269)
每年价格变化: -26.5% (0.4)
3年内价格变化: -69.05% (0.95)
5年内价格变化: -41.2% (0.5)
年初以来价格变化: -20.43% (0.3695)
所有参数

低估

姓名 意义 年级
P/S 17.5 1
P/BV 3.21 5
P/E 0 0
EV/EBITDA -2.48 0
全部的: 4.13

效率

姓名 意义 年级
ROA, % -96.01 0
ROE, % -116.95 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0377 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -67.2 0
盈利能力 Ebitda, % 55.27 7
盈利能力 EPS, % 2.05 1
全部的: 3
更多详情

机构 体积 分享, %
Blackrock Inc. 717884 1.81
Vanguard Group Inc 645166 1.63
Geode Capital Management, LLC 324296 0.82
State Street Corporation 184107 0.47
Dearborn Partners, L.L.C. 116710 0.29
Susquehanna International Group, LLP 76872 0.19
Northern Trust Corporation 71364 0.18
Bridgeway Capital Management, Inc. 69000 0.17
Goldman Sachs Group Inc 65495 0.17
Virtu Financial LLC 60723 0.15



导师 职称 支付 出生年份
Mr. Ram Mukunda President, CEO & Director 705k 1959 (66 年)
Ms. Claudia Grimaldi VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director 245k 1972 (53 年)
Mr. Rohit Goel Senior Director of Accounting & Principal Accounting Officer N/A 1994 (31 年)
Benysh Qureshi Esq., M.B.A. Director of Operations

地址: United States, Potomac. MD, 10224 Falls Road - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://igcpharma.com